A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy
出版年份 2023 全文链接
标题
A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy
作者
关键词
-
出版物
BMC Medical Genomics
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-03
DOI
10.1186/s12920-023-01719-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
- (2021) Yilan Jin et al. Pharmacogenomics & Personalized Medicine
- Effect of the allelic variants ofABCB1, CYP2D6andHTR3Bon response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients
- (2016) Gaeun Kang et al. Asia-Pacific Journal of Clinical Oncology
- An Analysis of Behavioral and Genetic Risk Factors for Chemotherapy-Induced Nausea and Vomiting in Japanese Subjects
- (2016) Naoki Mukoyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
- (2016) D Tsuji et al. PHARMACOGENOMICS JOURNAL
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer
- (2014) Dorit Pud et al. BREAST CANCER RESEARCH AND TREATMENT
- DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147)
- (2014) Adam M. Lee et al. JNCI-Journal of the National Cancer Institute
- Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer
- (2014) Jatinder Kaur Lamba et al. PHARMACOGENOMICS
- Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis
- (2013) Ikuo Sekine et al. CANCER SCIENCE
- Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study
- (2013) Amalia S Lehmann et al. BMC Pregnancy and Childbirth
- A first step towards the understanding of the 5-HT3 receptor subunit heterogeneity from a computational point of view
- (2012) Francesca De Rienzo et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy
- (2011) D. A. Perwitasari et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron
- (2010) M V Tzvetkov et al. PHARMACOGENOMICS JOURNAL
- First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
- (2008) Johannes Kapeller et al. HUMAN MOLECULAR GENETICS
- Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
- (2008) P. A. Fasching et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The 5-HT3 receptor – the relationship between structure and function
- (2008) Nicholas M. Barnes et al. NEUROPHARMACOLOGY
- Investigation ofHTR3Cmutations for association with 5HT3receptor antagonist anti-emetic efficacy
- (2008) Michael B Ward et al. PHARMACOGENOMICS
- Serotonin type 3 receptor genes:HTR3A, B, C, D, E
- (2008) Beate Niesler et al. PHARMACOGENOMICS
- High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor
- (2008) K. Krzywkowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now